Weekly alendronate-induced acute pseudogout
نویسندگان
چکیده
منابع مشابه
Weekly oral alendronate in mevalonate kinase deficiency
BACKGROUND Mevalonate kinase deficiency (MKD) is caused by mutations in the MVK gene, encoding the second enzyme of mevalonate pathway, which results in subsequent shortage of downstream compounds, and starts in childhood with febrile attacks, skin, joint, and gastrointestinal symptoms, sometimes induced by vaccinations. METHODS For a history of early-onset corticosteroid-induced reduction of...
متن کاملAcute pseudogout following intravenous neridronate for osteoporosis.
3. Information on permissions/orders of reprints in rheumatology and related fields. Silverman featuring research articles on clinical subjects from scientists working is a monthly international serial edited by Earl D.
متن کاملTherapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group.
Dosing convenience is a key element in the effective management of any chronic disease, and is particularly important in the long-term management of osteoporosis. Less frequent dosing with any medication may enhance compliance, thereby maximizing the effectiveness of therapy. Animal data support the rationale that once-weekly dosing with alendronate 70 mg (7 times the daily oral treatment dose)...
متن کاملPseudogout simulating acute suppurative arthritis.
In gout the first attack of arthritis is often acute and most painful. If the affected site is the first metatarso-phalangeal joint the diagnosis presents little difficulty. When larger joints are involved there is a risk that the condition may be mistaken for acute septic arthritis. A more positive approach to the diagnosis has recently been made possible by Seegmiller, Howell and Malawista (1...
متن کاملEfficacy and Safety of Weekly Alendronate Plus Vitamin D3 5600 IU versus Weekly Alendronate Alone in Korean Osteoporotic Women: 16-Week Randomized Trial
Vitamin D (vit-D) is essential for bone health, although many osteoporosis patients have low levels of 25-hydroxy-vit-D [25(OH)D]. This randomized, open-label study compared the effects of once weekly alendronate 70 mg containing 5600 IU vit-D₃ (ALN/D5600) to alendronate 70 mg without additional vit-D (ALN) on the percent of patients with vit-D insufficiency [25(OH)D <15 ng/mL, primary endpoint...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rheumatology
سال: 2005
ISSN: 1460-2172
DOI: 10.1093/rheumatology/keh428